RedTram News Search Engine
Русский  English Українська  Français  Polski  Deutsch  Italiano  Español  中文   
8 July 2008 year (time zone GMT 00:00)  Number of sources in English: 4955
Navigating the themes
Navigating the regions
All Themes Health & Beauty Pharmaceutics World
Pharmaceutics (World) RSS 2.0

Beijing Officials Ramp Up Olympic Marketing Ban

08.07.2008 23:24    brandweek.com
Unauthorized use of logos, ads from non-Olympic sponsors could lead to 'fine or punishment.'


Diageo's McMahan In as Heineken CMO

08.07.2008 23:24    brandweek.com
Guinness vet Christian McMahan succeeds Ken Kunze in top marketing role.

Custom Powder Systems

08.07.2008 14:30    pharmaceutical-technology.com
is strategically positioned as the leading provider of systems to transport, contain, blend, process and dry materials for pharmaceutical, biopharmaceutical, food, nutrition supplement and industrial manufacturing.It is our goal to provide you with:An easily accessible resource for developing processes to
World    Pharmaceutics    Press-releases

Vitrolife increases stake in ATS

Vitrolife, a biotechnology and medical device company, has acquired a further 9% of the shares in ATS, the distributor of Vitrolife's products in Italy.
World    Pharmaceutics    Articles


Eniva's nutraceutical found effective in human cell study

The Eniva Research Group has reported results from laboratory testing by the Linus Pauling Micronutrient Research Institute at Oregon State University which demonstrated the Eniva health supplement Vibe possessed DNA protective anti-mutagenic activity for human cells.
World    Pharmaceutics    Articles

LinkMed to acquire Olerup SSP

LinkMed, a private equity company in the life science sector, has said that it is acquiring 100% of the shares in Sweden-based biotechnology company Olerup SSP. The value of the acquisition is SEK216 million.
World    Pharmaceutics    Articles

ABL signs patent licensing agreement with Viralliance

ABL Patent Licensing Technologies, a subsidiary of Advanced Biological Laboratories, has entered into a patent licensing agreement with Viralliance.
World    Pharmaceutics    Articles

Axolotl appoints new marketing director

Axolotl, a provider of health information exchange technology solution, has named Carol Somer as its new marketing director.
World    Pharmaceutics    Articles

InTouch Health launches new stroke care solution

InTouch Technologies, doing business as InTouch Health, has launched its new product feature, StrokeRespond, to extend the functionality of its remote presence robotic technology for stroke experts.
World    Pharmaceutics    Articles

Probio to acquire Gelkaps

Probio Nutraceuticals has entered into an agreement to acquire Gelkaps, which manufactures pharmaceutical and nutraceutical grade soft gelatin capsules.
World    Pharmaceutics    Articles

BD Diagnostics granted CE Mark for GeneOhm Cdiff molecular assay

BD Diagnostics, a segment of Becton Dickinson and Company, has received CE mark for BD GeneOhm Cdiff molecular assay for the rapid diagnosis of patients with Clostridium difficile infection.
World    Pharmaceutics    Articles

Cell Biosciences appoints key executives

Cell Biosciences, a provider of ultra sensitive protein detection and characterization systems to life science researchers, has appointed Jason Novi as its new CFO.
World    Pharmaceutics    Articles

Fresenius to acquire APP Pharmaceuticals

Fresenius, a provider of dialysis and home medical care products, and APP Pharmaceuticals have entered into a definitive merger agreement pursuant to which Fresenius will acquire APP.
World    Pharmaceutics    Articles

Ceapro's CEO and president to step down

Ceapro has announced that Mark Redmond has decided to step down as a director and an officer of the company, effective immediately.
World    Pharmaceutics    Articles

Teva's Phase III multiple sclerosis study trial fails to demonstrate increased efficacy

Teva Pharmaceutical Industries has reported results from a Phase III study designed to assess the efficacy, safety and tolerability of glatiramer acetate 40mg as compared to the approved Copaxone 20mg in the treatment of relapsing-remitting multiple sclerosis.
World    Pharmaceutics    Articles

Sectra signs installation agreement with Sergas

Sectra, an IT and medical-technology company, has signed an agreement with Sergas, a provider of healthcare services for Galicia region in the northwest of Spain, to install PACS at five of the region's public hospitals.
World    Pharmaceutics    Articles

1